SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001824293-23-000016
Filing Date
2023-02-24
Accepted
2023-02-23 21:58:10
Documents
73
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ck0001824293-20221231.htm   iXBRL 10-K 1512971
2 EX-2.2 amendmenttomergeragreement.htm EX-2.2 13002
3 EX-10.30 amendmenttospas_ex1030.htm EX-10.30 16484
4 EX-23.1 auditorsconsent_ex231.htm EX-23.1 2620
5 EX-31.1 vlon-202210k_ex311.htm EX-31.1 10986
6 EX-31.2 vlon-202210k_ex312.htm EX-31.2 10964
7 EX-32.1 vlon-202210k_ex321.htm EX-32.1 5487
8 EX-32.2 vlon-202210k_ex322.htm EX-32.2 5478
  Complete submission text file 0001824293-23-000016.txt   5684751

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001824293-20221231.xsd EX-101.SCH 34578
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001824293-20221231_cal.xml EX-101.CAL 49211
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001824293-20221231_def.xml EX-101.DEF 149979
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001824293-20221231_lab.xml EX-101.LAB 487272
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001824293-20221231_pre.xml EX-101.PRE 323146
67 EXTRACTED XBRL INSTANCE DOCUMENT ck0001824293-20221231_htm.xml XML 647848
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40034 | Film No.: 23662200
SIC: 2834 Pharmaceutical Preparations